Inactivation of Apc perturbs mammary development, but only directly results in acanthoma in the context of Tcf-1 deficiency

Ronald C J Gallagher, Trevor Hay, Valerie Meniel, Catherine Naughton, Thomas J Anderson, Hiroyuki Shibata, Masaki Ito, Hans Clevers, Tetsuo Noda, Owen J Sansom, John O Mason, Alan R Clarke

Research output: Contribution to journalArticlepeer-review

Abstract

Apc (adenomatous polyposis coli) encodes a tumour suppressor gene that is mutated in the majority of colorectal cancers. Recent evidence has also implicated Apc mutations in the aetiology of breast tumours. Apc is a component of the canonical Wnt signal transduction pathway, of which one target is Tcf-1. In the mouse, mutations of both Apc and Tcf-1 have been implicated in mammary tumorigenesis. We have conditionally inactivated Apc in both the presence and absence of Tcf-1 to examine the function of these genes in both normal and neoplastic development. Mice harbouring mammary-specific mutations in Apc show markedly delayed development of the mammary ductal network. During lactation, the mice develop multiple metaplastic growths which, surprisingly, do not spontaneously progress to neoplasia up to a year following their induction. However, additional deficiency of Tcf-1 completely blocks normal mammary development and results in acanthoma.
Original languageEnglish
Pages (from-to)6446-57
Number of pages12
JournalOncogene
Volume21
Issue number42
DOIs
Publication statusPublished - 2002

Fingerprint

Dive into the research topics of 'Inactivation of Apc perturbs mammary development, but only directly results in acanthoma in the context of Tcf-1 deficiency'. Together they form a unique fingerprint.

Cite this